scholarly journals Interventional Echocardiography: Field of Advanced Imaging to Support Structural Heart Interventions

2018 ◽  
Vol 12 (1) ◽  
pp. 22-27
Author(s):  
Roy Arjoon ◽  
Ashley Brogan ◽  
Lissa Sugeng
Keyword(s):  
Heart Disease ◽  
Transesophageal Echocardiography ◽  
3D Imaging ◽  
Multimodality Imaging ◽  
Structural Heart Disease ◽  
Advanced Imaging ◽  
Cardiac Defects ◽  
Interventional Echocardiography ◽  
2D And 3D

Multimodality imaging, particularly echocardiography, is paramount in planning and guiding structural heart disease interventions. Transesophageal echocardiography remains unique in its ability to provide real-time 2D and 3D imaging of valvular heart disease and anatomic cardiac defects, which directly impacts the strategy and outcome of these procedures. This review summarizes the role of transesophageal echocardiography in patients undergoing the most common structural heart disease interventions.

scholarly journals The Role of Multimodality Imaging in Left-Sided Prosthetic Valve Dysfunction

2022 ◽  
Vol 9 (1) ◽  
pp. 12
Author(s):  
Manuela Muratori ◽  
Laura Fusini ◽  
Maria Elisabetta Mancini ◽  
Gloria Tamborini ◽  
Sarah Ghulam Ali ◽  
...  
Keyword(s):  
Prosthetic Valve ◽  
Multimodality Imaging ◽  
Integrated Approach ◽  
Advanced Imaging ◽  
Valve Dysfunction ◽  
Clinical Presentations ◽  
Imaging Approach ◽  
Treatment Administration ◽  
Life Threatening

Prosthetic valve (PV) dysfunction (PVD) is a complication of mechanical or biological PV. Etiologic mechanisms associated with PVD include fibrotic pannus ingrowth, thrombosis, structural valve degeneration, and endocarditis resulting in different grades of obstruction and/or regurgitation. PVD can be life threatening and often challenging to diagnose due to the similarities between the clinical presentations of different causes. Nevertheless, identifying the cause of PVD is critical to treatment administration (thrombolysis, surgery, or percutaneous procedure). In this report, we review the role of multimodality imaging in the diagnosis of PVD. Specifically, this review discusses the characteristics of advanced imaging modalities underlying the importance of an integrated approach including 2D/3D transthoracic and transesophageal echocardiography, fluoroscopy, and computed tomography. In this scenario, it is critical to understand the strengths and weaknesses of each modality according to the suspected cause of PVD. In conclusion, for patients with suspected or known PVD, this stepwise imaging approach may lead to a simplified, more rapid, accurate and specific workflow and management.

Role of Autonomic Tone in the Initiation and Termination of Paroxysmal Atrial Fibrillation in Patients Without Structural Heart Disease

2003 ◽  
Vol 14 (6) ◽  
pp. 559-564 ◽  
Author(s):  
Takeshi Tomita ◽  
Manabu Takei ◽  
Yuko Saikawa ◽  
Takeshi Hanaoka ◽  
Shin‐Ichiroh Uchikawa ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Heart Disease ◽  
Paroxysmal Atrial Fibrillation ◽  
Structural Heart Disease ◽  
Autonomic Tone

Echocardiography in the cath lab: Fusion imaging and use of intracardiac echocardiography

2021 ◽  
pp. 121-128
Author(s):  
Covadonga Fernández-Golfín ◽  
José Luis Zamorano
Keyword(s):  
Heart Disease ◽  
Structural Heart Disease ◽  
Transoesophageal Echocardiography ◽  
Fusion Imaging ◽  
Intracardiac Echocardiography ◽  
Imaging Modalities ◽  
Fusion System ◽  
Basic Principles ◽  
Fused Image

Structural heart disease interventions represent a new branch of percutaneous treatments rapidly expanding. Imaging, mainly transoesophageal echocardiography is essential to guide the procedures along with fluoroscopy. In the last year, fusion of both imaging modalities is available with dedicated software that allows the visualization of both echo and fluoro in a single fused image. These systems allow a better anatomic depiction of the different structures allowing safer and faster procedures with a better communication between the interventionalists and the imagers. In this chapter we will review the basic principles of these fusion system and main uses as well as the role of intracardiac echocardiography in the cath lab.

Ventricular arrhythmias

2019 ◽  
pp. 221-240
Author(s):  
Martin Borggrefe ◽  
Erol Tülümen ◽  
Josep Brugada
Keyword(s):  
Heart Disease ◽  
Ventricular Arrhythmias ◽  
Arrhythmogenic Right Ventricular Cardiomyopathy ◽  
Atrioventricular Node ◽  
Structural Heart Disease ◽  
Polymorphic Ventricular Tachycardia ◽  
European Society Of Cardiology ◽  
Ventricular Tachycardias ◽  
Current Guidelines

Ventricular arrhythmias are abnormal rhythms that originate from below the atrioventricular node. They include premature ventricular complexes, ventricular tachycardias, and ventricular fibrillation. Ventricular arrhythmias may occur in patients with structural heart disease (ischaemic heart disease, cardiomyopathies such as dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, etc.) or in patients with a structurally normal heart (genetic arrhythmia syndromes such as long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or as idiopathic ventricular tachycardias). Symptoms depend on the frequency, duration, and haemodynamic effects of the arrhythmia. They may be asymptomatic or may cause symptoms, such as palpitations, shortness of breath, chest discomfort, dizziness, or syncope, or may present with cardiac arrest. This chapter is focused on the role of antiarrhythmic drugs in the management of ventricular arrhythmias. The recommendations are based on the current guidelines of the European Society of Cardiology for the management of patients with ventricular arrhythmias.

scholarly journals The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia

2016 ◽  
Vol 5 (1) ◽  
pp. 45 ◽  
Author(s):  
Krystien VV Lieve ◽  
◽  
Arthur A Wilde ◽  
Christian van der Werf ◽  
◽  
...  
Keyword(s):  
Heart Disease ◽  
Ventricular Tachycardia ◽  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Structural Heart Disease ◽  
Current Data ◽  
Catecholaminergic Polymorphic Ventricular Tachycardia ◽  
Polymorphic Ventricular Tachycardia ◽  
Β Blockers

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but severe genetic cardiac arrhythmia disorder, with symptoms including syncope and sudden cardiac death due to polymorphic VT or ventricular fibrillation typically triggered by exercise or emotions in the absence of structural heart disease. The cornerstone of medical therapy for CPVT is β -blockers. However, recently flecainide has been added to the therapeutic arsenal for CPVT. In this review we summarise current data on the efficacy and role of flecainide in the treatment of CPVT.

scholarly journals The role of multimodality imaging in HIV-related heart disease

2020 ◽  
Author(s):  
Sudeep Raj Aryal ◽  
Navkaranbir S. Bajaj ◽  
Gregory Von Mering ◽  
Mustafa I. Ahmed
Keyword(s):  
Heart Disease ◽  
Multimodality Imaging
Sign in / Sign up

Export Citation Format

Share Document